Join our Newsletter
Browse by Category
-
Most Read This Week
- Vical Incorporated announces results of herpes vaccine trial
- NIH studying newly emerging Staphylococcus aureus strain
- Japan deals with rubella outbreak
- University of Cincinnati researchers develop oral breast cancer vaccine
- CDC issues update on fungal meningitis outbreak
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: H5N1
Medicago receives authorization for phase II clinical trial
Tweet Medicago, Inc., announced on Monday that it has received authorization from Health Canada to conduct phase II clinical trials for its H5N1 vaccine. There have been three medical trials performed on a total of 403 subjects for Medicago’s H5N1 … Read More »
Study of bird flu mutations improves ability to develop vaccines
Tweet Scientists from Imperial College London found that mutations in the H5N1 bird flu virus could allow the disease to replicate more easily in the noses of mammals, according to a recent study. The results of the study could help … Read More »
H5N1 vaccine succeeds in Phase 1 clinical trials
Tweet Positive results of a H5N1 vaccine clinical trial were recently announced at the World Vaccine Congress in Washington, D.C. H5N1 is a flu virus normally found in birds and domestic poultry that rarely infects humans. There is always a … Read More »
IDRI and Medicago will present at World Vaccine Congress
TweetThe Infectious Disease Research Institute and Medicago, Inc., announced on Tuesday that they will present positive interim Phase I clinical results for a H5N1 vaccine candidate at the World Vaccine Congress on April 17. IDRI, a Seattle-based non-profit research organization, … Read More »
Study of bird flu mutation offers vaccine clue
Tweet Scientists have found small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals, which may help find a vaccine for the virus. While there have only been isolated cases of … Read More »
New vaccine could be used to treat H5N1, H9 bird flu strains
Tweet Recent research revealed that a new vaccine may be effective in treating the highly lethal H5N1 bird flu and H9 strain of bird flu, which most experimental vaccines have been unable to treat. The vaccine, which uses a “live” … Read More »
UCLA creates method to predict possible pandemic origin locations
TweetResearchers from the University of California Los Angeles have used a new method of analyzing flu surveillance and other data to predict that coastal and central China and Egypt’s Nile Delta may become hotspots during the next pandemic influenza outbreak. … Read More »
New models to predict pandemic flu
Tweet Researchers from the University of California Los Angeles are creating new means to predict where a major new influenza outbreak is likely to emerge. Experts fear of what would happen in the event of H5N1 highly pathogenic avian influenza … Read More »